COVID-19 Treatments

Treatments for those who have or had COVID-19

Overview

The Department of Health encouraged individuals age 5 and up to consider receiving a COVID-19 vaccine to protect themselves from the SARS-CoV-2 virus. In the event someone does contract COVID-19, their doctor may prescribe medications or infusions to prevent serious illness. Treatments used for COVID-19 should be prescribed by your healthcare provider. The Centers for Disease Control and Prevention reports that people have been seriously harmed and even died after taking products not approved for COVID-19, even products approved or prescribed for other uses.

For COVID-19 related questions, call (314) 657-1499 or email health@stlouis-mo.gov.

Medications Approved or Authorized for Use

  • The Food and Drug Administration (FDA) has approved one drug, remdesivir (Veklury), to treat COVID-19.
  • The FDA can also issue emergency use authorizations (EUAs) to allow healthcare providers to use products that are not yet approved, or that are approved for other uses, to treat patients with COVID-19 if certain legal requirements are met.
  • The National Institutes of Health (NIH) has developed and regularly updates Treatment Guidelines to help guide healthcare providers caring for patients with COVID-19, including when clinicians might consider using one of the products under an EUA.

Treatment Outside of the Hospital

Your healthcare provider might recommend the following to relieve symptoms and support your body’s natural defenses:

  • Taking medications, like acetaminophen or ibuprofen, to reduce fever
  • Drinking water or receiving intravenous fluids to stay hydrated
  • Getting plenty of rest to help the body fight the virus

If you are more likely to get very sick from COVID-19

Your healthcare provider might recommend that you receive investigational treatment.

  • For people at high risk of disease progression. The FDA has issued EUAs for a number of  investigational monoclonal antibodies that can attach to parts of the virus. These antibodies could help the immune system recognize and respond more effectively to the virus. The NIH COVID-19 Treatment Guidelines provide information about these drugs and describe what is known about their effectiveness. If used, they should be administered as soon as possible after diagnosis and within 10 days of symptom onset. Your healthcare provider will decide whether these investigational treatments are appropriate to treat your illness.
    • The City of St. Louis Department of Health has partnered with Affinia Healthcare to provide monoclonal antibody treatment in the City of St. Louis. For information on this treatment or to schedule and appointment, please call 314-449-3553.
      NOTE: Walk-ups are not permitted for monoclonal antibody treatment. 

Treatment in the Hospital

  • Slowing the virus. Antiviral medications reduce the ability of the virus to multiply and spread through the body.
  • Reducing an overactive immune response. In patients with severe COVID-19, the body’s immune system may overreact to the threat of the virus, worsening the disease. This can cause damage to the body’s organs and tissues. Some treatments can help reduce this overactive immune response.
  • Treating complications. COVID-19 can damage the heart, blood vessels, kidneys, brain, skin, eyes, and gastrointestinal organs. It also can cause other complications. Depending on the complications, additional treatments might be used for severely ill hospitalized patients, such as blood thinners to prevent or treat blood clots.
  • Supporting the body’s immune function. Plasma from patients who have recovered from COVID-19—called convalescent plasma—can contain antibodies to the virus. This could help the immune system recognize and respond more effectively to the virus, but currently the NIH COVID-19 Treatment Guidelines find there is not enough evidence to recommend these treatments.

Was this page helpful?      



Comments are helpful!
500 character limit

Feedback is anonymous.